An observational study in Adolescent, Female and Menstruation, sponsored by Saglik Bilimleri Universitesi. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 10 Years to 19 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-10.
Sponsored by Saglik Bilimleri Universitesi · Observational
The goal of this observational study is to examine menstrual characteristics and symptoms in adolescent volleyball athletes compared to non-athlete adolescents. The main question it aims to answer is:
How do menstrual symptoms and characteristics differ between adolescent volleyball athletes and non-athletes?
The study included 154 adolescents aged 10-19, divided into 77 volleyball athletes (average age 15.09) and 77 non-athletes (average age 14.79). Assessments covered menstruation age, regularity, dysmenorrhea characteristics, and menstrual symptoms using the Menstrual Symptom Questionnaire (MSQ).
The goal of this observational study is to investigate menstrual characteristics and symptoms in adolescent volleyball athletes compared to non-athlete adolescents. The main question it aims to answer is:
How do menstrual symptoms and characteristics differ between adolescent volleyball athletes and their non-athlete peers?
The study included 154 adolescents aged 10-19 who had experienced menarche for at least one year. Participants were divided into two groups: 77 volleyball athletes (average age 15.09±1.33) and 77 non-athletes (average age 14.79±1.27). Assessments included menstruation age, regularity, use of menstruation delay pills, cycle characteristics (length, duration), and dysmenorrhea characteristics (onset, frequency, medication use, school/training absenteeism). The Menstrual Symptom Questionnaire (MSQ) evaluated menstrual pain, coping methods, and somatic complaints.
Saglik Bilimleri Universitesi is the lead sponsor of 447 studies on the registry; 138 are open to participants now.
Counted across the registry records on this site, refreshed daily.
10-19 years old females
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
willingness to participate in the research, female gender, experience of menstruation cycles for at least 1 year, age between 10 and 19 years, volleyball sport license for at least 3 years, and practice of volleyball at least 4 days a week for at least 3 years
willingness to participate in the research, female gender, experience of menstruation cycles for at least 1 year, age between 10 and 19 years,
Menstrual Pain
Menstruation related pain ( pain in the first 3 days of menstruation) intensity will be measured as a primary outcome using the the Visual Analog Scale (VAS). This outcome will measure the level of pain experienced by participants and the results will be reported as a continuous variable. The VAS consists of a 10 cm horizontal line with endpoints labeled "no pain" (0) and "worst pain imaginable" . Participants will mark the point on the line that best represents their pain intensity. The scores range from 0 (no pain) to 10 (worst pain), with higher scores indicating worse pain.
Time frame: 3 months ( will cover 3 menstrual cyles)
Menstrual symptoms (assessed using the Menstruation Symptom Questionnaire)
Menstrual symptoms will be assessed using the Menstruation Symptom Questionnaire (MSQ) designed to measure the severity and frequency of physical and emotional symptoms associated with menstruation (Negative Effects/Somatic Complaints, Menstrual Pain, and Coping Methods). The MSQ consists of 24 items, each rated on a 5-point Likert scale where 0 indicates no symptoms and 5 indicates the most severe symptoms. The total MSQ score ranges from 0 to 120, with higher scores reflecting worse menstrual symptoms.
Time frame: 3 months. The outcome will be evaluated before starting the study and after 12 weeks. It will be reported as a continuous variable to quantify changes in symptom severity over time.
Plan to share: No — Participants datas will not be shared till publicaiton is confirmed
No publications or documents are linked to this record.
Ran from Jan 2024 to primary completion in Mar 2024, 2 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Saglik Bilimleri Universitesi →